LNTH - Lantheus Holdings, Inc.
NASDAQ
->
Healthcare
->
Diagnostics & Research
North Billerica,
United States
Type: Equity
LNTH price evolution
LNTH
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $713.66 | $614.13 | $414.08 | $470.86 |
| Short term investments | ||||
| Net receivables | $284.29 | $259.2 | $256.28 | $242.11 |
| Inventory | $64.03 | $56.46 | $51.8 | $42.16 |
| Total current assets | $1085.82 | $948.43 | $752.22 | $773.27 |
| Long term investments | ||||
| Property, plant & equipment | $146.7 | $140.29 | $129.98 | $127.48 |
| Goodwill & intangible assets | $213.17 | $224.48 | $282.19 | $281.05 |
| Total noncurrent assets | $565.33 | $573.17 | $585.5 | $576.01 |
| Total investments | ||||
| Total assets | $1651.15 | $1521.61 | $1337.72 | $1349.28 |
| Current liabilities | ||||
| Accounts payable | $41.19 | $37.08 | $38.86 | $30.8 |
| Deferred revenue | ||||
| Short long term debt | $0.82 | $0.7 | $0.38 | $0.42 |
| Total current liabilities | $187.35 | $176.6 | $154.04 | $276.39 |
| Long term debt | $561.67 | $560.58 | $559.24 | $558.54 |
| Total noncurrent liabilities | $647.91 | $646.25 | $631.03 | $627.38 |
| Total debt | $562.49 | $561.28 | $559.62 | $558.96 |
| Total liabilities | $835.26 | $822.85 | $785.08 | $903.77 |
| Shareholders' equity | ||||
| Retained earnings | $133.5 | $30.12 | -$101.83 | -$195.97 |
| Other shareholder equity | -$1.04 | -$1.03 | -$0.95 | -$1.38 |
| Total shareholder equity | $815.89 | $698.76 | $552.64 | $445.52 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $713.66 | $415.65 | $98.51 | $79.61 |
| Short term investments | ||||
| Net receivables | $284.29 | $213.4 | $89.34 | $54 |
| Inventory | $64.03 | $35.48 | $35.13 | $35.74 |
| Total current assets | $1085.82 | $677.62 | $235.79 | $184.22 |
| Long term investments | ||||
| Property, plant & equipment | $146.7 | $141.2 | $116.77 | $120.17 |
| Goodwill & intangible assets | $213.17 | $376.47 | $409.7 | $434.64 |
| Total noncurrent assets | $565.33 | $643.64 | $627.99 | $685.6 |
| Total investments | ||||
| Total assets | $1651.15 | $1321.26 | $863.78 | $869.82 |
| Current liabilities | ||||
| Accounts payable | $41.19 | $20.56 | $20.79 | $16.28 |
| Deferred revenue | ||||
| Short long term debt | $0.82 | $0.35 | $11.64 | $20.7 |
| Total current liabilities | $187.35 | $247.7 | $90.5 | $80.5 |
| Long term debt | $561.67 | $557.71 | $163.12 | $197.7 |
| Total noncurrent liabilities | $647.91 | $626.41 | $308.85 | $275.11 |
| Total debt | $562.49 | $558.07 | $174.76 | $218.4 |
| Total liabilities | $835.26 | $874.11 | $399.35 | $355.62 |
| Shareholders' equity | ||||
| Retained earnings | $133.5 | -$193.16 | -$221.22 | -$149.95 |
| Other shareholder equity | -$1.04 | -$1.26 | -$0.48 | -$2.05 |
| Total shareholder equity | $815.89 | $447.15 | $464.44 | $514.21 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $354 | $319.95 | $321.7 | $300.78 |
| Cost of revenue | $124.13 | $120 | $119.05 | $223.71 |
| Gross Profit | $229.87 | $199.95 | $202.65 | $77.08 |
| Operating activities | ||||
| Research & development | $16.82 | $14.45 | $15.9 | $30.53 |
| Selling, general & administrative | $75.56 | $73.14 | $62.61 | $55.89 |
| Total operating expenses | $92.38 | $87.59 | $78.51 | $86.42 |
| Operating income | $137.49 | $112.36 | $124.14 | -$9.34 |
| Income from continuing operations | ||||
| EBIT | $143.44 | $165.01 | $128.62 | -$6.11 |
| Income tax expense | $35.02 | $28 | $29.56 | -$8.3 |
| Interest expense | $5.04 | $5.05 | $4.93 | $4.99 |
| Net income | ||||
| Net income | $103.38 | $131.96 | $94.13 | -$2.81 |
| Income (for common shares) | $103.38 | $131.96 | $94.13 | -$2.81 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1296.43 | $935.06 | $425.21 | $339.41 |
| Cost of revenue | $586.89 | $353.36 | $237.51 | $200.65 |
| Gross Profit | $709.54 | $581.7 | $187.69 | $138.76 |
| Operating activities | ||||
| Research & development | $77.71 | $311.68 | $44.97 | $32.79 |
| Selling, general & administrative | $267.19 | $233.83 | $218.82 | $110.17 |
| Total operating expenses | $344.9 | $545.51 | $248.52 | $142.96 |
| Operating income | $364.64 | $36.2 | -$60.83 | -$4.2 |
| Income from continuing operations | ||||
| EBIT | $430.96 | $33.9 | -$67.29 | -$2 |
| Income tax expense | $84.28 | -$1.35 | -$3.76 | $1.99 |
| Interest expense | $20.02 | $7.18 | $7.75 | $9.48 |
| Net income | ||||
| Net income | $326.66 | $28.07 | -$71.28 | -$13.47 |
| Income (for common shares) | $326.66 | $28.07 | -$71.28 | -$13.47 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $103.38 | $131.96 | $94.13 | -$2.81 |
| Operating activities | ||||
| Depreciation | $15.02 | $14.65 | $15.76 | $14.62 |
| Business acquisitions & disposals | $97.84 | -$10 | -$35.34 | |
| Stock-based compensation | $14.17 | $13.98 | $12.69 | $9.67 |
| Total cash flows from operations | $112.29 | $116.74 | -$32.27 | $108.5 |
| Investing activities | ||||
| Capital expenditures | -$12.07 | -$14.62 | -$10.7 | -$9.17 |
| Investments | ||||
| Total cash flows from investing | -$12.07 | $83.22 | -$20.7 | -$44.51 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.35 | $1.27 | $1.35 | $2.78 |
| Net borrowings | -$0.03 | -$0.16 | -$0.23 | -$0.3 |
| Total cash flows from financing | -$0.45 | $0.11 | -$4.05 | -$8.67 |
| Effect of exchange rate | -$0.23 | $0.24 | -$0.1 | |
| Change in cash and equivalents | $99.54 | $200.06 | -$56.78 | $55.22 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $326.66 | $28.07 | -$71.28 | -$13.47 |
| Operating activities | ||||
| Depreciation | $60.04 | $47.93 | $42.29 | $24.69 |
| Business acquisitions & disposals | $52.49 | -$258.2 | $15.82 | $17.56 |
| Stock-based compensation | $50.51 | $29.26 | $15.93 | $14.07 |
| Total cash flows from operations | $305.26 | $281.78 | $53.92 | $16.4 |
| Investing activities | ||||
| Capital expenditures | -$46.55 | -$18.35 | -$12.14 | -$12.47 |
| Investments | -$10 | |||
| Total cash flows from investing | $5.94 | -$276.55 | $3.68 | -$4.91 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $5.75 | -$66.09 | $6.06 | $0.76 |
| Net borrowings | -$0.72 | $382.27 | -$43.35 | -$15.49 |
| Total cash flows from financing | -$13.06 | $311.69 | -$39.33 | -$21.86 |
| Effect of exchange rate | -$0.09 | -$0.34 | -$0.31 | $0.15 |
| Change in cash and equivalents | $298.04 | $316.59 | $17.96 | -$10.22 |
News
Fundamentals
| Market cap | $4.47B |
|---|---|
| Enterprise value | $4.32B |
| Shares outstanding | 68.52M |
| Revenue | $1.30B |
|---|---|
| EBITDA | $491.00M |
| EBIT | $430.96M |
| Net Income | $326.66M |
| Revenue Q/Q | 34.52% |
| Revenue Y/Y | 38.65% |
| P/E ratio | 13.68 |
|---|---|
| EV/Sales | 3.33 |
| EV/EBITDA | 8.79 |
| EV/EBIT | 10.02 |
| P/S ratio | 3.45 |
| P/B ratio | 5.47 |
| Book/Share | 11.92 |
| Cash/Share | 10.41 |
| EPS | $4.77 |
|---|---|
| ROA | 22.30% |
| ROE | 52.00% |
| Debt/Equity | 1.02 |
|---|---|
| Net debt/EBITDA | 0.25 |
| Current ratio | 5.80 |
| Quick ratio | 5.45 |